TCM
IMVT icon

TCG Crossover Management’s Immunovant IMVT Stock Holding History

TCG Crossover Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111M Buy
4,457,988
+2,797,055
+168% +$72.4M 3.17% 8
2025
Q4 		$42.2M Buy
+1,660,933
New +$37M 1.4% 20
2023
Q4 		– Sell
-334,853
Closed -$12.9M – 30
2023
Q3 		$12.9M Sell
334,853
-320,000
-49% -$7.23M 1.89% 21
2023
Q2 		$12.4M Hold
654,853
– – 2.04% 14
2023
Q1 		$10.2M Sell
654,853
-200,000
-23% -$3.47M 1.98% 15
2022
Q4 		$15.2M Buy
+854,853
New +$10.8M 2.68% 14

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return